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Abstract
Background: Ca2+-activated Cl- channels (CaCCs) participate in many important physiological
processes. However, the lack of effective and selective blockers has hindered the study of these
channels, mostly due to the lack of good assay system. Here, we have developed a reliable drug
screening method for better blockers of CaCCs, using the endogeneous CaCCs in Xenopus laevis
oocytes and two-electrode voltage-clamp (TEVC) technique.
Results: Oocytes were prepared with a treatment of Ca2+ ionophore, which was followed by a
treatment of thapsigargin which depletes Ca2+ stores to eliminate any contribution of Ca2+ release.
TEVC was performed with micropipette containing chelerythrine to prevent PKC dependent run-
up or run-down. Under these conditions, Ca2+-activated Cl- currents induced by bath application
of Ca2+ to oocytes showed stable peak amplitude when repetitively activated, allowing us to test
several concentrations of a test compound from one oocyte. Inhibitory activities of commercially
available blockers and synthesized anthranilic acid derivatives were tested using this method. As a
result, newly synthesized N-(4-trifluoromethylphenyl)anthranilic acid with trifluoromethyl group (-
CF3) at para position on the benzene ring showed the lowest IC50.
Conclusion: Our results provide an optimal drug screening strategy suitable for high throughput
screening, and propose N-(4-trifluoromethylphenyl)anthranilic acid as an improved CaCC blocker.
Background
Ca2+-activated Cl- channels (CaCCs) are anion-selective
channels that can be activated by an increase in cytosolic
Ca2+. CaCCs serve a number of important physiological
roles in a variety of cell types. These functions include vas-
cular tone regulation, cardiac excitability, smooth muscle
contraction, fast block of polyspermy in certain eggs [1].
CaCCs are also known to regulate epithelial secretion of
electrolytes and water in kidneys, airways, intestines, pan-
creas and salivary glands [1]. In addition, CaCCs appear to
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participate in signal processing of olfactory transduction,
photo receptor light response, gustation and somaesthetic
sensation by regulating neuronal cell excitability. CaCC
currents in non-sensory neurons of the spinal cord and
the autonomic nervous system were also reported, and
further investigation may prove an even more extensive
expression in the nervous system [2]. Despite this physio-
logical importance of CaCC, the channel remains poorly
understood at the molecular, biophysical and pharmaco-
logical level, owing to the lack of specific pharmacologic
tools with high potent and selectivity. Currently available
blockers require high concentrations to completely block
CaCCs and are known to cause undesirable side effects
and block other channels. For example, niflumic acid and
4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid
(DIDS) which are widely used to block CaCC also block
volume-regulated anion channel (VRAC) in some cell
types [3,4]. Niflumic acid, flufenamic acid and 5-nitro-2-
(3-phenylpropylamino)-benzoic acid (NPPB) are shown
to have a blocking effect on K+ channel current [5,6]. Nif-
lumic acid, flufenamic acid and NPPB also cause an
increase in intracellular Ca2+ concentration ([Ca2+]i) in
several cell types, which could elicit other cellular
responses [7-11]. Therefore, due to these problems with
low potency and selectivity, there is an eminent need for
development of better blockers for CaCCs.
Xenopus laevis oocytes have been used widely in the field
of electrophysiology to study the structure and the func-
tion of numerous ion channels and to screen for selective
blockers. These oocytes express several native ion chan-
nels including CaCC in the plasma membrane [12],
which are normally avoided when studying other ion
channels by substituting Ca2+ with Ba2+ in the extracellular
solution in attempt to prevent activation of endogenous
CaCCs. These CaCCs have similar properties in many
ways to those in cardiac muscle, smooth muscle, secretory
epithelial cells and neurons [13]. There have been a
numerous attempts to discover chemical compounds to
block the endogenous CaCCs in Xenopus laevis oocytes
using TEVC (two-electrode voltage clamp) technique.
These studies reported half maximal inhibition concentra-
tion (IC50) of various compounds, including niflumic
acid (17 μM of, IC50) [14], flufenamic acid (28 μM of
IC50) [14], DIDS (48 μM of IC50) [13], diphenylamine-2-
carboxylate (DPC, 111 μM of IC50) [13], 9-anthracene car-
boxylic acid (9-AC, 10.3 μM of IC50) [13] and NPPB (22–
68 μM of IC50) [15]. But the potency of these blockers is
relatively low. In other studies, CaCC current was evoked
by direct intracellular injection of Ca2+ into an oocyte
[12,16] or by depolarizing the membrane which allows
Ca2+ entry through voltage gated Ca2+ channels [17-19].
However, these approaches can introduce complications
of unstable baseline current due to irregular amplification
of Ca2+ concentration upon Ca2+ entry, unpredictable con-
tribution of Ca2+ release from intracellular stores and time
dependent inactivation of CaCCs, making it difficult to
perform large scale drug screening. Based on the observa-
tion that no reliable method of drug screening and no
ideal blocker of CaCC in Xenopus laevis oocytes have yet
been described, we sought to design an optimized experi-
mental protocol ideal for large scale drug screening to find
better blockers for CaCCs.
Results
Cl- current elicited by Ca2+ influx in oocytes permeabilized 
with ionomycin
To find optimal conditions for drug screening using
CaCCs in Xenopus oocytes, we first characterized the CaCC
currents in Xenopus oocytes and compared various treat-
ment conditions. To permeablize the oocyte membrane to
allow Ca2+ influx, oocytes were treated with 10 μM iono-
mycin for 30 min in Ca2+ free solution. In oocytes, Ca2+
entry and activation of an inward current were achieved
by switching from Ca2+ free external solution to Ca2+ con-
taining solution [20]. After membrane permeabilization,
application of external Ca2+ evoked Cl- currents consisting
of fast peak (Ifast) and slow steady state component (Islow,
Figure 1C) [20]. The fast component was elicited by 5 s
exposure to extracellular Ca2+ ([Ca2+]o) in a dose depend-
ant manner (Figure 1A) and calculated EC50 for [Ca2+]o
was 4.89 mM (n = 9) (Figure 1B). Therefore, 5 mM [Ca2+]o
was used to induce Cl- current in all subsequent experi-
ments. Ifast and Islow were not induced by substituting Ca2+
with Ba2+ in each condition (Figure 1E, F, I, J, N, O), indi-
cating that both of these currents were activated by Ca2+
entry.
In response to repetitive 5 s applications of the same dose
of [Ca2+]o, the amplitude of 2nd response was smaller
compared to the initial response (Ifast
2nd/Ifast
1st = 0.89 ±
0.04, Figure 1M, white bar), most likely due to an activa-
tion of a Ca2+-dependent protein kinase C (PKC) [21]. To
exclude the effect of PKC in CaCC current, PKC inhibitor
chelerythrine was added to the intracellular solution.
Inclusion of chelerythrine decreased the variability repre-
sented by the standard error of mean value (Ifast
2nd/Ifast
1st
= 0.85 ± 0.013, Figure 1M, black bar), but still the 2nd
response remained smaller than the 1st response (Figure
1D). Additional variability in peak amplitude can come
from the Ca2+  induced Ca2+  release from intracellular
stores. To eliminate the contribution of Ca2+ release from
intracellular stores, Ca2+ ATPase inhibitor, thapsigargin
was treated on ionomycin pretreated oocytes. Under the
condition of ionomycin treatment followed by thapsi-
gargin treatment and recording with chelerythrine added
intracellular solution, the peak amplitudes of two consec-
utive responses to 5 mM external Ca2+ were almost the
same with relatively low standard error of mean value
(Figure 1H, Ifast
2nd/Ifast
1st = 1.01 ± 0.02 (n = 7), Figure 1M,Molecular Brain 2008, 1:14 http://www.molecularbrain.com/content/1/1/14
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Endogeneous Ca2+ activated Cl- channels in Xenopus laevis oocyte Figure 1
Endogeneous Ca2+ activated Cl- channels in Xenopus laevis oocyte. (A) Currents induced by extracellular Ca2+ in a 
dose dependent manner on ionomycin treated oocyte. (B) Dose response and EC50 of Ca2+ obtained from (A). (C~F) Currents 
recorded after treatment of ionomycin without thapsigargin treatment. (C, G) Fast peak and slow component during Ca2+ 
applications. (G~J) Currents recorded after treatment of ionomycin followed by thapsigargin. (D, H) Second application of 
Ca2+ induces slightly reduced fast peak amplitude compared to the first peak. (E, I) Ba2+ does not induce the slow component. 
(F, J) Ba2+ does not induce the fast peak. (K~O) Comparison of currents under each condition. CHE+ means that current was 
measured with chelerythrine added intracellular solution. TG+ indicates that thapsigargin was treated on ionomycin pretreated 
oocytes. (K) Fast peak amplitude. (L) Slow component amplitude. (M) Summary of the experiments shown in (D) and (H); 
Ratio of amplitude induced by the first and the second Ca2+. (N) Summary of the experiments shown in (E) and (I). (O) Sum-
mary of the experiments shown in (F) and (J). n indicates number of oocytes. Error bars indicate SEMs. * indicates statistically 
significant difference by two-tailed t-test. *, p < 0.05; **, p < 0.01; ***, p < 0.001
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gray bar). Therefore, a reliable protocol for drug screening
of CaCCs in Xenopus oocytes was established with treat-
ment of 1 μM thapsigargin for 90 min to ionomycin
treated oocytes followed by recording with microelec-
trodes filled with intracellular solution containing 1 μM
chelerythrine.
Effect of known blockers and commercially available 
chemical compounds on CaCC in Xenopus oocytes
Using the optimized drug screening protocol, the effect of
known blockers of CaCC was tested. Over the concentra-
tion range tested (1 μM – 300 μM), each of the typical
CaCC blockers caused a concentration dependent block
of CaCC currents (Figure 2A) and IC50s were obtained
from the dose-response curves (Figure 2B). The name and
structure for each chemical compound are listed in Figure
3, and each chemical compound was numbered as shown
on top of each chemical structure. From the recordings,
IC50s were found to be 10.7 μM for DIDS, 32.3 μM for
NPPB, 94.3 μM for 9-AC, 37.3 μM for niflumic acid, and
35.4 μM for flufenamic acid (Figure 2C, Figure 3A, Table
1). Other blockers generally known for other Cl- channels
were also tested under the same condition. IC50s were
found to be 44.5 μM for mefenamic acid and 88.1 μM for
N-Phenylanthranilic acid. Except for DIDS, most of
known blockers displayed higher IC50 values compared to
the previously reported values (Table 1).
We searched for other commercially available chemical
compounds that have similar structure to known block-
ers. Since flufenamic acid, mefenamic acid and N-Phe-
nylanthranilic acid commonly have anthranilic acid
backbone, which is composed of two benzene rings,
anthranilic acids containing a nitro group (-NO2) such as
5-Nitro-N-phenylanthranilic acid (a-8), N-(2-Nitrophe-
nyl)anthranilic acid (b-1) and N-(3-Nitrophe-
nyl)anthranilic acid (b-2) were tested (Figure 3A, B). IC50s
were 42.5 μM for a-8 and 32.1 μM for b-2. b-1 showed low
potency for CaCC block (Figure 3A, B, Table 1). Interest-
ingly, even though a-8, b-1 and b-2 have a similar chemi-
cal composition, their blocking effect on CaCC was quite
different. The only difference between three chemical
compounds is the position of -NO2. Therefore, the posi-
tion of substituent group on benzene ring of the
anthranilic acid backbone apparently affected the block-
ing effect on CaCC.
Positional effect of substituent group of benzene ring on 
block of CaCC current
To examine the positional effect of -NO2 of benzene ring
on block of CaCC current in more detail, we synthesized
compounds with substitutions on the benzene ring (see
additional file 1). We synthesized N-(4-nitrophe-
nyl)anthranilic acid (b-3) that has -NO2 on its para posi-
tion and tested for the block of CaCC current. This
compound showed a significantly improved IC50 of 17.8
μM, compared to b-1 that has -NO2 on its ortho position
(IC50 > 200 μM) or b-2 that has – NO2 on its meta position
(IC50= 32.1 μM Figure 4A). Based on the fact that blocking
effects of -NO2 on the benzene ring of either side of
Table 1: IC50s of known blockers and anthranilic acid derivatives.
Compound number Chemical compound IC50 *I C 50 n
a-1 DIDS 48 10.7 6
a-2 NPPB (5-nitro-2-(3-phenylpropylamino)benzoic acid) 22–68 32.3 6
a-3 9-AC (9-anthracene carboxylic acid) 10.3 94.3 5
a-4 Niflumic acid 17 37.3 7
a-5 Flufenamic acid (N-(3-Trifluoromethylphenyl)anthranilic acid) 28 35.4 6
a-6 Mefenamic acid 44.5 6
a-7 N-Phenylanthranilic acid 88.1 6
a-8 5-Nitro-N-phenylanthranilic acid 42.5 8
b-1 N-(2-Nitrophenyl)anthranilic acid LP 7
b-2 N-(3-Nitrophenyl)anthranilic acid 32.1 7
b-3 N-(4-Nitrophenyl)anthranilic acid 17.8 6
b-4 5-Nitro-N-(4-nitrophenyl)anthranilic acid 15.4 5
b-5 N-(2-Trifluoromethylphenyl)anthranilic acid 29.5 6
b-6 N-(4-Trifluoromethylphenyl)anthranilic acid 6.0 6
b-7 N-(4-Fluoro-3-trifluoromethylphenyl)anthranilic acid 14.7 6
c-1 N-(4-Fluorophenyl)anthranilic acid 63.1 6
c-2 N-(4-Chlorophenyl)anthranilic acid 11.3 6
c-3 N-(4-Methylphenyl)anthranilic acid 55.3 7
c-4 N-(4-Isopropylphenyl)anthranilic acid 17.0 6
c-5 N-(4-tert-Butylphenyl)anthranilic acid 22.9 7
c-6 N-(4-Decylphenyl)anthranilic acid LP 6
c-7 N-(4-Methoxyphenyl)anthranilic acid 102.3 5
IC50 * means IC50 previously studied. LP: Low Potency. IC50 > 200 μM n indicates number of oocytes.Molecular Brain 2008, 1:14 http://www.molecularbrain.com/content/1/1/14
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anthranilic acid backbone (a-8, b-3) showed improved
IC50 compared to the N-Phenylanthranilic acid itself (a-
7), we synthesized 5-Nitro-N-(4-nitrophenyl)anthranilic
acid (b-4) that has -NO2 on its para position on both ben-
zene rings. Interestingly, IC50 of b-4 was further enhanced
(IC50 = 15.4 μM) than a-8 and b-3, indicating that substit-
uent group on para position should enhance the blocking
effect.
Since flufenamic acid (N-(3-trifluoromethylphe-
nyl)anthranilic acid, a-5) has trifluoromethyl group (-
CF3) in meta position, we hypothesized that shifting -CF3
from meta position to ortho or para position would result
in changes in IC50. We synthesized N-(2-trifluoromethyl-
phenyl)anthranilic acid (b-5) that has -CF3 on its ortho
position and N-(4-trifluoromethylphenyl)anthranilic
acid (b-6) that has -CF3 on its para position. b-5 showed
enhanced IC50 (IC50 = 29.5 μM) than a-5 (Figure 3B, 4B).
In particular, b-6 dramatically enhanced the IC50 com-
pared to any other compounds (IC50= 6.0 μM, Figure 3B,
4B). These data indicate that changing the position of sub-
stituent group on the benzene ring of anthranilic acid
backbone to para position leads to an increase in blocking
activity.
Effect of known blockers on Ca2+ activated Cl- channel Figure 2
Effect of known blockers on Ca2+ activated Cl- channel. (A) Trace of Ca2+ activated Cl- channel current before and dur-
ing application of flufenamic acid (FA). (B) Dose response relation of flufenamic acid block of Ca2+ activated Cl- current. (C) 
Summary of IC50s of commercially available blockers for Ca2+-activated Cl- channel. n indicates number of oocytes. Error bars 
indicate SEMs.
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Chemical structures and IC50s of known blockers and anthranilic acid derivatives Figure 3
Chemical structures and IC50s of known blockers and anthranilic acid derivatives. (A) Known blockers. (B) 
Anthranilic acid derivatives; positional compounds. (C) Anthranilic acid derivatives that have variable substituent group on para 
position of benzene ring. LP: Low Potency. IC50 > 200 μM. n indicates number of oocytes.
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Comparison of blocking effect about anthranilic acid 
derivatives on CaCC
Since para positioned anthranilic acid derivatives showed
higher potency of block, we synthesized more anthranilic
acid derivatives that have various substituents on para
position of the benzene ring and tested on CaCC currents.
However, blocking activity of these derivatives was not
better than b-5 with -CF3 on para position as indicated by
their IC50s: c-2 (chloryl group, -Cl, IC50 = 11.3 μM), c-4
(isopropyl group, -C3H7, IC50 = 17.0 μM) and c-5 (butyl
Positional effect of substituent group on the phenyl ring of blocker that affects block of Ca2+-activated Cl- current Figure 4
Positional effect of substituent group on the phenyl ring of blocker that affects block of Ca2+-activated Cl- cur-
rent. (A) Comparison of chemical structure, IC50 and dose response between N-(2-nitrophenyl)anthranilic acid, N-(3-nitroph-
enyl)anthranilic acid and N-(4-nitrophenyl)anthranilic acid in which the nitro (-NO2) group on the benzene ring is positioned at 
ortho, meta and para position. (B) Comparison of chemical structure, IC50 and dose response between flufenamic acid and 
derivatives N-(2-trifluoromethylphenyl)anthranilic acid and N-(4-trifluoromethylphenyl)anthranilic acid in which the trifluor-
omethyl (-CF3) group on the benzene ring is positioned at ortho, meta and para position. Shaded boxes indicate the substituent 
groups tested. n indicates number of oocytes. Error bars indicate SEMs.
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group, – C4H9, IC50 = 22.9 μM (Figure 3C, Table 1). In
addition, N-(4-Fluorophenyl)-anthranilic acid (c-1, IC50 =
63.1  μM),  N-(4-Methylphenyl)-anthranilic acid (c-3,
IC50= 55.3 μM), N-(4-Decylphenyl)-anthranilic acid (c-6,
IC50> 200 μM) and N-(4-Methoxyphenyl)-anthranilic
acid (c-7, IC50 = 102.3 μM) which have fluoro group (-F),
methyl group (-CH3), decyl group (-CH2(CH2)8CH3) and
methoxy group (-OCH3) showed relatively low potency
for CaCC block, respectively (Figure 3C, Table 1). There-
fore, the most potent derivative among the compounds
tested was the N-(4-trifluoromethylphenyl)anthranilic
acid that has -CF3 on its para position with IC50 of 6.0 μM.
Discussion
Since the lack of useful tools for drug screening has
impeded the development of better blocker for CaCCs, we
designed an improved drug screening protocol utilizing
endogeneous CaCCs in Xenopus  oocytes. Our newly
designed protocol consists of Xenopus Leavis oocytes
treated with ionomycin and thapsigargin followed by
recording with intracellular solution containing cheler-
ythrine. These manipulations provide a consistent induc-
tion of CaCC mediated currents with similar amplitude
upon repeated application of 5 mM external Ca2+. Treat-
ment of ionomycin allows constant entry of Ca2+ from
extracellular solution, whereas thapsigargin prevents
irregular concentration fluctuations caused by Ca2+ release
amplification from internal stores. Elevation of intracellu-
lar Ca2+ due to Ca2+ influx through Ca2+ channels formed
by ionomycin should cause inactivation of the CaCC con-
ductance via activation of PKC [21]. Thus, inhibition of
PKC should decrease the channel modulation by PKC
phosphorylation, which was shown to modulate the
CaCC current [22]. Thus, intracellular solution containing
PKC inhibitor chelerythrine was used for recording of
CaCC current to exclude the effect of PKC. Under these
conditions, the intracellular Ca2+ concentration was kept
constant during induction of CaCC current, and current
rundown due to PKC inactivation was kept at minimal
level. These manipulations made it possible to measure
blocking effect of various compounds on CaCC-mediated
current in Xenopus leavis oocytes more accurately.
In addition, some blockers such as niflumic acid change
the intracellular Ca2+ buffering which causes an increase
in intracellular Ca2+ concentration [7-11]. Since Cl- cur-
rent is induced exclusively by external Ca2+ in our proto-
col, we were able to isolate the blocking effect of various
compounds on channel activities from the effect of com-
pounds on Ca2+ buffering capacity.
Utilizing this optimized protocol, we first compared the
effect of known blockers of CaCC. We found that IC50s of
DIDS, NPPB, 9-AC, niflumic acid and flufenamic acid on
CaCC current in Xenopus oocytes were 10.7 μM (DIDS),
32.3 μM (NPPB), 94.3 μM (9-AC), 37.3 μM (niflumic
acid) and 35.4 μM (flufenamic acid), whereas previously
reported values are 48 μM, 28–68 μM, 10.3 μM, 17 μM
and 28 μM, respectively (see Table 1). Blocking effect of
each known blocker differed from previous reports. It is
likely due to differences in our protocol. We suggest that
our modified screening protocol provides more exact pro-
file of CaCC blocker on CaCC in Xenopus Leavis oocytes
due to the reliability and repeatability of our assay proto-
col. In addition, some blockers that were generally used
for other Cl- channels such as mefenamic acid and N-Phe-
nylanthranilic acid showed comparable blocking effect on
CaCC in Xenopus Leavis oocytes with IC50s of 44.5 μM and
88.1 μM.
Based on the fact that several known blockers of CaCCs
have structural similarity as anthranilic acid which is com-
posed of two benzene rings, we searched for CaCC blocker
candidates with the structural similarity among commer-
cially available chemical compounds. Even though, the
number of compounds were not enough to explain exact
SAR (structure-activity relationship), we could figure out
the correlation between biological activity and the kind
and position of substituents. We found that 5-Nitro-N-
phenylanthranilic acid and N-(3-Nitrophenyl)anthranilic
acid both showed similar level of blocking effect as niflu-
mic acid or flufenamic acid. Interestingly, blocking
potency was quite different between N-(3-Nitrophe-
nyl)anthranilic and N-(2-Nitrophenyl)anthranilic acid
even though their chemical composition is identical,
except for the relative position of -NO2 in the benzene
ring. This reflected that the position of -NO2 affected the
blocking activity to CaCC. Synthesized N-(4-Nitrophe-
nyl)anthranilic acid that has -NO2 on its para  position
showed improved blocking ability compare to N-(3-
Nitrophenyl)anthranilic and N-(2-Nitrophe-
nyl)anthranilic acid with -NO2 on meta and ortho position,
respectively. Likewise, synthesized N-(4-trifluoromethyl-
phenyl)anthranilic acid that has -CF3 on its para position
blocked CaCC better than flufenamic acid (N-(3-trifluor-
omethylphenyl)anthranilic acid) and N-(2-trifluorometh-
ylphenyl)anthranilic acid with -CF3 on  meta  and  ortho
position, respectively. These results suggested that the
positioning of substituent group on para site contributes
to a higher affinity of these compounds to CaCC. There-
fore, we concluded that antrhranilic acid derivatives con-
taining  para  positioned substituent group have high
potency of CaCC block.
Additionally synthesized chemical compounds are
anthranilic acid derivatives that have various substituent
groups such as various hydrocarbons introduced into the
benzene ring at para position. IC50s of N-(4-Chlorophe-
nyl)-anthranilic acid, N-(4-Isopropylphenyl)-anthranilic
acid and N-(4-tert-Butylphenyl)-anthranilic acid wereMolecular Brain 2008, 1:14 http://www.molecularbrain.com/content/1/1/14
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similar in IC50  of  N-(4-Nitrophenyl)anthranilic acid.
However, low blocking effect was shown in N-(4-Fluor-
ophenyl)-anthranilic acid, N-(4-Methylphenyl)-
anthranilic acid and N-(4-Decylphenyl)-anthranilic acid.
These results suggested that there should be no strong cor-
relation between blocking effect and size of substituent
group in CaCC blockers. It has been reported that blocker
size affects voltage dependence rather than potency of
CaCC block because large blockers lodge at sites less deep
in the channel [1]. Taken together, N-(4-trifluoromethyl-
phenyl)anthranilic acid that has -CF3 on its para position
in one benzene ring is most potent CaCC blocker candi-
date so far.
Ion channels endogeneously expressed in Xenopus Leavis
oocytes have extensively used in biological and pharma-
cological research. CaCCs in Xenopus Leavis oocytes have
similar properties in many ways to those in other tissue. It
has been revealed that several human diseases are
involved in CaCCs. However, its molecular identity is not
clear yet. Recently, CLCA [23,24], bestrophin [25], tweety
[26] and TMEM16A [27] have been proposed as the
molecular candidates. It is important to note that blocker
candidates confirmed in Xenopus Leavis oocytes should be
also examined in these candidate molecules and CaCCs in
other various tissues. Nevertheless, several common
blockers for CaCCs have undesirable side effects: they can
affect the cellular Ca2+ level [7-11], and block VRACs [3]
and K+ channels [5,6]. Recent study also identified that
niflumic acid, flufenamic acid and Indomethacin are non-
steroidal anti-inflammatory drug (NSAID) that have
inhibitor potencies against both cyclo-oxygenase (COX) 1
and 2 [28]. Considering the structural similarity, other
candidates of CaCC blocker may have the similar side
effects. Therefore, future experiments should be followed
to test whether blocker candidates show decreased side
effects.
Conclusion
This study has shown the development of reliable screen-
ing method for CaCC blocker using endogeneous CaCCs
in Xenopus laevis oocytes. We found that anthranilic acid
derivatives containing para positioned substituent group
have high potency of CaCC block and N-(4-trifluor-
omethylphenyl)anthranilic acid is most effective CaCC
blocker among the synthesized chemical compounds.
Methods
Preparation of oocytes
Matured stage V–VI oocytes [29] harvested from adult
Xenopus laevis females (Xenopus I, Michigan, USA) which
were maintained in an automated maintenance system,
Xenopus System (Aquatic Habitats, Florida, USA). The
animals were anaesthetized by cooling with ice [30].
Ovarian follicles were surgically removed, treated with 2
mg/ml collagenase type IA at room temperature for 90
min in Ca2+ free Barth's solution containing 89 mM NaCl,
1.0 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4 and 10
mM HEPES (pH 7.4). The oocytes were extensively rinsed
with normal Barth's solution containing 88 mM NaCl, 1.0
mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4, 0.33 mM
Ca(NO3)2, 1.41 mM CaCl2 and 5 mM HEPES (pH 7.4),
placed in culture Barth's solution containing 88 mM
NaCl, 1.0 mM KCl, 2.4 mM NaHCO3, 0.82 mM MgSO4,
0.33 mM Ca(NO3)2, 0.91 mM CaCl2, 10 mM HEPES, 10
μg/ml streptomycin and 10 μg/ml penicillin (pH 7.4),
and maintained at 18°C. Oocytes were used 1–4 days
after isolation.
Synthesis
All commercially available chemicals were reagent grade
and used as purchased unless stated otherwise. All reac-
tions were performed under an inert atmosphere of dry
argon or nitrogen using distilled dry solvents. Reactions
were monitored by TLC analysis using Merck silica gel 60
F-254 thin layer plates. Flash column chromatography
was carried out on Merck silica gel 60 (230–400 mesh) by
preparative LC system. 1H and 13C NMR spectra were
recorded either on a spectrometer operating at Bruker 400
and 100 MHz, respectively. Preparations of chemicals are
described in detail in Additional file 1.
Electrophysiology
To permeabilize the membrane to Ca2+, oocytes were
incubated in the oocyte recording solution containing 96
mM NaCl, 2 mM KCl, 2 mM MgCl2, 0.5 mM EGTA and 10
mM HEPES (pH 7.4), added with 10 μM ionomycin for
30 min. The ionomycin was then removed from the exter-
nal solution by washing with oocyte recording solution.
In case of thapsigargin treatment, ionomycin treated
oocytes were subsequently incubated in the oocyte record-
ing solution containing 1 μM thapsigargin for 90 min.
Then thapsigargin was also washed with the oocyte
recording solution. Two electrode voltage-clamp record-
ings were made using Warner model OC725B two-elec-
trode voltage clamp amplifier (Warner Instruments, Inc.,
Hamden, CT) with 1 M KCl-filled microelectrodes (WPI;
Sarasota, FL; 1B150F-4) pulled with a P-97 programmable
pipette puller (Sutter Instruments Co.; Novato, CA). The
pipettes had resistances of 1–3 MΩ. During the recording
oocytes were continuously perfused with oocyte recording
solution. All recordings were from a holding potential of
-60 mV. Drugs were prepared in separate bottles and
applied by gravity. Flow of solutions was approximately 1
ml/min.
Chemicals
Chemical compounds including the following reagents
were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA); Collagenase type 1A, ionomycin-Ca2+ salt, thapsi-Molecular Brain 2008, 1:14 http://www.molecularbrain.com/content/1/1/14
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gargin, chelerythrine. HEPES (N-[2-hydroxyethyl]pipera-
zine-N'-[ethanesulfonic acid]) was obtained from J.T
Baker (Mallinckrodt Baker, Inc. Phillipsburg, NJ, USA).
Analysis of data
Currents were digitally recorded with AxoScope software
(Axon Instruments, Burlingame, CA, USA) and data anal-
ysis was done with SigmaPlot 10.0 (Systat Software, Inc.,
CA, USA). All the current responses during a blocker were
normalized to the average of a Ca2+ induced Cl- current
applied before blocker application. Normalized and aver-
age data were fitted to the SigmaPlot's Logistic, 3 Parame-
ter curve to determine dose-response relationship and
IC50. All data are expressed as mean ± standard error of
mean and statistical analysis was performed using a 2-
tailed t-test.
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